Spin out companies from 黑料网吃瓜爆料 research

is a private medical technology company with a vision to offer lung cancer biopsy and treatment in a single hospital visit - spun-out in April 2024

has developed a proprietary cell-based transcription factor screening technology and associated peptide-based transcription factor inhibitors for the treatment of cancer. Revolver's unique platform identifies peptides that not only bind but also functionally inhibit transcription factors. These peptide inhibitors are stabilised using the company's patented crosslinking technology - spun-out in February 2023

develops software integrated within healthcare systems to help clinicians diagnose diseases more quickly - spun-out in April 2022
specialises in ultra-light aerogels that can be used as soundproofing and heat-shielding materials for the aerospace and automotive industries - spun-out in April 2022

develops ensilication technology to prevent degradation and spoilage of vaccines - spun-out in July 2021
develops a wearable technology platform to improve the prevention, diagnosis, and management of chronic conditions such as diabetes- spun-out in July 2021
improves human health through early detection and treatment of wound, bladder and skin infection, specialising in burn care, diabetic foot ulcer management and urology - spun-out in March 2021

created a suite of software tools to help researchers working with biomolecules to rapidly prediction changes in protein stability - incorporated in September 2019

provides software and consulting solutions for additively manufactured (3D printed) components - spun-out in May 2018 and acquired by in June 2022
produces biodegradable cellulose microparticles to replace plastic microbeads - spun-out in May 2018
provides risk minimisation, risk quantification and trajectory planning for drone operators and service providers - spun-out in July 2018 and rebranded as in March 2022

develops bioelectronics based on chip technology to mimic nerve centres within the body to help control autonomic or rhythmical processes such as heart rate - spun-out in February 2016

gathers, analyses and presents feedback from beneficiaries for an impact assessment of significant drivers of change in their lives - spun-out in December 2015

is a leading life science data provider for antibodies and biochemicals - spun-out in May 2013
is a biotech company that has developed a new patented bioprocessing technology for the growing and expansion of organoids - spun-out in April 2013

commercialises hollow-core photonic crystal fiber (HC-PCF) and their functionalised form Photonic Microcells鈩� (PMC) - spun-out in December 2008

creates antibody-drug conjugates to target difficult-to-treat cancers including those resistant or refractory to current therapies - spun-out as Glythera Ltd in November 2007 and rebranded as Iksuda Therapeutics Ltd in May 2018
develops and manufactures microwave ablation devices for minimally invasive soft tissue ablation - spun-out as Microsulis Medical Ltd in August 2007 and acquired by in March 2022
manufactures state-of-the-art compressed air and gas solutions for industry - spun-out in May 2007 and acquired by in February 2016
provides Nanocolumn technology to develop free standing gallium nitride substrates which are critical for blue and green laser technology and ultra-high brightness LEDs - spun-out in March 2007 and acquired by in 2009

manufactures pharmaceutical products under parent company Qualasept Pharmaxo Holdings Ltd - spun-out in May 2006

improves sexual health and wellness through new delivery methods - spun-out as Atlas Genetics in July 2005 and rebranded to Binx Health in October 2018

is a biopharmaceutical group improving lives through innovative medicines in oncology,聽neuroscience聽and rare diseases - spun-out in March 1997 and acquired by in 2004

黑料网吃瓜爆料